JD.Com Inc vs Revolution Medicines Inc. Common Stock — how do they compare? JD.Com Inc trades at $27.1 (market cap $36.62B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: JD.Com Inc and Revolution Medicines Inc. Common Stock are close in size by market cap, and JD.Com Inc pays a 3.72% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold JD.Com Inc for 85 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| JD | RVMD | |
|---|---|---|
Market Cap | $36.62B | $40.32B |
Volume | 6,571,477 | 4,855,734 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.53 | $221.15 |
52-Week Low | $25.19 | $47.50 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $19.26B | $37.02B |
Dividend Yield | 3.72% | — |
Signals from Pluang's Aura AI — not financial advice
JD.com (JD) trades at $27.09, up 0.22% on the day, with a bullish technical signal despite mixed moving averages. The stock is deeply undervalued with a P/E of 17.9 and P/S of 0.2, supported by strong cash flow and a robust balance sheet with $234 billion in cash. Recent Q2 2026 earnings beat expectations with EPS of $0.93, and the company is progressing on its $2.5 billion acquisition of Ceconomy, pending EU approval (Reuters, 2026-10-02).
The outlook is positive with a consensus price target of $35.86, implying 32% upside, and 70% of analysts rate it a Buy. Risks include revenue declines, regulatory scrutiny from China and the EU, and competitive pressures. The stock's discount to intrinsic value and strong liquidity position offer a compelling opportunity for long-term investors despite near-term headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →